{"id":"https://openalex.org/W1995076802","doi":"https://doi.org/10.1016/j.ymthe.2006.07.010","title":"Gene Therapy Based on Gemcitabine Chemosensitization Suppresses Pancreatic Tumor Growth","display_name":"Gene Therapy Based on Gemcitabine Chemosensitization Suppresses Pancreatic Tumor Growth","publication_year":2006,"publication_date":"2006-09-27","ids":{"openalex":"https://openalex.org/W1995076802","doi":"https://doi.org/10.1016/j.ymthe.2006.07.010","mag":"1995076802","pmid":"https://pubmed.ncbi.nlm.nih.gov/17000136"},"language":"en","primary_location":{"id":"doi:10.1016/j.ymthe.2006.07.010","doi":"https://doi.org/10.1016/j.ymthe.2006.07.010","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.ymthe.2006.07.010","pdf_url":"http://www.cell.com/article/S1525001606016364/pdf","source":{"id":"https://openalex.org/S51596929","display_name":"Molecular Therapy","issn_l":"1525-0016","issn":["1525-0016","1525-0024"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Therapy","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"http://www.cell.com/article/S1525001606016364/pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5012560255","display_name":"Fabienne Vernejoul","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I4210123497","display_name":"H\u00f4pital Rangueil","ror":"https://ror.org/034zn5b34","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3019448017","https://openalex.org/I4210123497"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Fabienne Vernejoul","raw_affiliation_strings":["INSERM U531, Institut Louis Bugnard IFR31, Centre Hospitalier Universitaire Rangueil, 31403 Toulouse Cedex 4, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"INSERM U531, Institut Louis Bugnard IFR31, Centre Hospitalier Universitaire Rangueil, 31403 Toulouse Cedex 4, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I4210123497"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061800971","display_name":"Laurent Gh\u00e9nassia","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210142058","display_name":"InvivoGen (France)","ror":"https://ror.org/03fdne361","country_code":"FR","type":"company","lineage":["https://openalex.org/I4210142058"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Laurent Gh\u00e9nassia","raw_affiliation_strings":["Research Department, Cayla InvivoGen Company, ZI Montaudran, 31400 Toulouse, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research Department, Cayla InvivoGen Company, ZI Montaudran, 31400 Toulouse, France","institution_ids":["https://openalex.org/I4210142058"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072966767","display_name":"Anny Souque","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I4210123497","display_name":"H\u00f4pital Rangueil","ror":"https://ror.org/034zn5b34","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3019448017","https://openalex.org/I4210123497"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Anny Souque","raw_affiliation_strings":["INSERM U531, Institut Louis Bugnard IFR31, Centre Hospitalier Universitaire Rangueil, 31403 Toulouse Cedex 4, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"INSERM U531, Institut Louis Bugnard IFR31, Centre Hospitalier Universitaire Rangueil, 31403 Toulouse Cedex 4, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I4210123497"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044926442","display_name":"Hubert Lulka","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I4210123497","display_name":"H\u00f4pital Rangueil","ror":"https://ror.org/034zn5b34","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3019448017","https://openalex.org/I4210123497"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Hubert Lulka","raw_affiliation_strings":["INSERM U531, Institut Louis Bugnard IFR31, Centre Hospitalier Universitaire Rangueil, 31403 Toulouse Cedex 4, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"INSERM U531, Institut Louis Bugnard IFR31, Centre Hospitalier Universitaire Rangueil, 31403 Toulouse Cedex 4, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I4210123497"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045142559","display_name":"Daniel Drocourt","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210142058","display_name":"InvivoGen (France)","ror":"https://ror.org/03fdne361","country_code":"FR","type":"company","lineage":["https://openalex.org/I4210142058"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Daniel Drocourt","raw_affiliation_strings":["Research Department, Cayla InvivoGen Company, ZI Montaudran, 31400 Toulouse, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research Department, Cayla InvivoGen Company, ZI Montaudran, 31400 Toulouse, France","institution_ids":["https://openalex.org/I4210142058"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081053692","display_name":"Pierre Cordelier","orcid":"https://orcid.org/0000-0003-2096-7967","observed_orcids":["https://orcid.org/0000-0003-2096-7967"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I4210123497","display_name":"H\u00f4pital Rangueil","ror":"https://ror.org/034zn5b34","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3019448017","https://openalex.org/I4210123497"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Pierre Cordelier","raw_affiliation_strings":["INSERM U531, Institut Louis Bugnard IFR31, Centre Hospitalier Universitaire Rangueil, 31403 Toulouse Cedex 4, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"INSERM U531, Institut Louis Bugnard IFR31, Centre Hospitalier Universitaire Rangueil, 31403 Toulouse Cedex 4, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I4210123497"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039575338","display_name":"Lucien Pradayrol","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I4210123497","display_name":"H\u00f4pital Rangueil","ror":"https://ror.org/034zn5b34","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3019448017","https://openalex.org/I4210123497"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Lucien Pradayrol","raw_affiliation_strings":["INSERM U531, Institut Louis Bugnard IFR31, Centre Hospitalier Universitaire Rangueil, 31403 Toulouse Cedex 4, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"INSERM U531, Institut Louis Bugnard IFR31, Centre Hospitalier Universitaire Rangueil, 31403 Toulouse Cedex 4, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I4210123497"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058448191","display_name":"St\u00e9phane Pyronnet","orcid":"https://orcid.org/0000-0002-9562-5112","observed_orcids":["https://orcid.org/0000-0002-9562-5112"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I4210123497","display_name":"H\u00f4pital Rangueil","ror":"https://ror.org/034zn5b34","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3019448017","https://openalex.org/I4210123497"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"St\u00e9phane Pyronnet","raw_affiliation_strings":["INSERM U531, Institut Louis Bugnard IFR31, Centre Hospitalier Universitaire Rangueil, 31403 Toulouse Cedex 4, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"INSERM U531, Institut Louis Bugnard IFR31, Centre Hospitalier Universitaire Rangueil, 31403 Toulouse Cedex 4, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I4210123497"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077103144","display_name":"Louis Buscail","orcid":"https://orcid.org/0000-0003-4276-1003","observed_orcids":["https://orcid.org/0000-0003-4276-1003"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I4210123497","display_name":"H\u00f4pital Rangueil","ror":"https://ror.org/034zn5b34","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3019448017","https://openalex.org/I4210123497"]}],"countries":["FR"],"is_corresponding":true,"raw_author_name":"Louis Buscail","raw_affiliation_strings":["INSERM U531, Institut Louis Bugnard IFR31, Centre Hospitalier Universitaire Rangueil, 31403 Toulouse Cedex 4, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"INSERM U531, Institut Louis Bugnard IFR31, Centre Hospitalier Universitaire Rangueil, 31403 Toulouse Cedex 4, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I4210123497"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5110398639","display_name":"G\u00e9rard Tiraby","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210142058","display_name":"InvivoGen (France)","ror":"https://ror.org/03fdne361","country_code":"FR","type":"company","lineage":["https://openalex.org/I4210142058"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"G\u00e9rard Tiraby","raw_affiliation_strings":["Research Department, Cayla InvivoGen Company, ZI Montaudran, 31400 Toulouse, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research Department, Cayla InvivoGen Company, ZI Montaudran, 31400 Toulouse, France","institution_ids":["https://openalex.org/I4210142058"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5077103144"],"corresponding_institution_ids":["https://openalex.org/I154526488","https://openalex.org/I4210123497"],"apc_list":{"value":4500,"currency":"USD","value_usd":4500},"apc_paid":{"value":4500,"currency":"USD","value_usd":4500},"fwci":1.8443,"has_fulltext":false,"cited_by_count":52,"citation_normalized_percentile":{"value":0.84248028,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":99},"biblio":{"volume":"14","issue":"6","first_page":"758","last_page":"767"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10613","display_name":"Virus-based gene therapy research","score":0.5830000042915344,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10613","display_name":"Virus-based gene therapy research","score":0.5830000042915344,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10231","display_name":"Pancreatic and Hepatic Oncology Research","score":0.32280001044273376,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10725","display_name":"RNA Interference and Gene Delivery","score":0.03280000016093254,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pancreatic-cancer","display_name":"pancreatic cancer","score":0.800000011920929},{"id":"https://openalex.org/keywords/gemcitabine","display_name":"gemcitabine","score":0.9580000042915344},{"id":"https://openalex.org/keywords/chemosensitization","display_name":"chemosensitization","score":0.9829999804496765},{"id":"https://openalex.org/keywords/gene-therapy","display_name":"gene therapy","score":0.8309999704360962},{"id":"https://openalex.org/keywords/deoxycytidine-kinase","display_name":"deoxycytidine kinase","score":0.9129999876022339},{"id":"https://openalex.org/keywords/fusion-genes","display_name":"fusion genes","score":0.9129999876022339},{"id":"https://openalex.org/keywords/intratumoral-gene-transfer","display_name":"intratumoral gene transfer","score":0.7549999952316284},{"id":"https://openalex.org/keywords/polyethylenimine","display_name":"polyethyleneimine","score":0.9589999914169312},{"id":"https://openalex.org/keywords/bystander-effect","display_name":"bystander effect","score":0.7680000066757202},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.9810000061988831},{"id":"https://openalex.org/keywords/tumor-regression","display_name":"tumor regression","score":0.8399999737739563}],"concepts":[{"id":"https://openalex.org/C2780258809","wikidata":"https://www.wikidata.org/wiki/Q414143","display_name":"Gemcitabine","level":3,"score":0.9100626707077026},{"id":"https://openalex.org/C2779268695","wikidata":"https://www.wikidata.org/wiki/Q14914175","display_name":"Deoxycytidine kinase","level":5,"score":0.8509271144866943},{"id":"https://openalex.org/C2780210213","wikidata":"https://www.wikidata.org/wiki/Q212961","display_name":"Pancreatic cancer","level":3,"score":0.8052318096160889},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.7260395288467407},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.43505120277404785},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3928767442703247},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.37571343779563904},{"id":"https://openalex.org/C2777844706","wikidata":"https://www.wikidata.org/wiki/Q422504","display_name":"Deoxycytidine","level":4,"score":0.2892891466617584},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.23425182700157166},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.17515939474105835}],"mesh":[{"descriptor_ui":"D000093542","descriptor_name":"Gemcitabine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000964","descriptor_name":"Antimetabolites, Antineoplastic","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D000964","descriptor_name":"Antimetabolites, Antineoplastic","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000964","descriptor_name":"Antimetabolites, Antineoplastic","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D002470","descriptor_name":"Cell Survival","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D003841","descriptor_name":"Deoxycytidine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D003841","descriptor_name":"Deoxycytidine","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D003841","descriptor_name":"Deoxycytidine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D003842","descriptor_name":"Deoxycytidine Kinase","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D003842","descriptor_name":"Deoxycytidine Kinase","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D005822","descriptor_name":"Genetic Vectors","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D006224","descriptor_name":"Cricetinae","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008647","descriptor_name":"Mesocricetus","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009374","descriptor_name":"Neoplasms, Experimental","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":false},{"descriptor_ui":"D009703","descriptor_name":"Nucleoside-Phosphate Kinase","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D009703","descriptor_name":"Nucleoside-Phosphate Kinase","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D010190","descriptor_name":"Pancreatic Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D010190","descriptor_name":"Pancreatic Neoplasms","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D015316","descriptor_name":"Genetic Therapy","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D017209","descriptor_name":"Apoptosis","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/j.ymthe.2006.07.010","doi":"https://doi.org/10.1016/j.ymthe.2006.07.010","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.ymthe.2006.07.010","pdf_url":"http://www.cell.com/article/S1525001606016364/pdf","source":{"id":"https://openalex.org/S51596929","display_name":"Molecular Therapy","issn_l":"1525-0016","issn":["1525-0016","1525-0024"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Therapy","raw_type":"journal-article"},{"id":"pmid:17000136","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17000136","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular therapy : the journal of the American Society of Gene Therapy","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1016/j.ymthe.2006.07.010","doi":"https://doi.org/10.1016/j.ymthe.2006.07.010","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.ymthe.2006.07.010","pdf_url":"http://www.cell.com/article/S1525001606016364/pdf","source":{"id":"https://openalex.org/S51596929","display_name":"Molecular Therapy","issn_l":"1525-0016","issn":["1525-0016","1525-0024"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Therapy","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.98580002784729}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":false},"content_urls":{"pdf":"https://content.openalex.org/works/W1995076802.pdf"},"referenced_works_count":38,"referenced_works":["https://openalex.org/W1503210522","https://openalex.org/W1527742565","https://openalex.org/W1555309303","https://openalex.org/W1578924338","https://openalex.org/W1902196118","https://openalex.org/W1905254767","https://openalex.org/W1930516194","https://openalex.org/W1931508686","https://openalex.org/W1965189214","https://openalex.org/W1980224748","https://openalex.org/W1981099237","https://openalex.org/W1982772769","https://openalex.org/W2009044337","https://openalex.org/W2010281770","https://openalex.org/W2010833449","https://openalex.org/W2019026359","https://openalex.org/W2021856189","https://openalex.org/W2033312723","https://openalex.org/W2035590181","https://openalex.org/W2047546794","https://openalex.org/W2052340069","https://openalex.org/W2076649038","https://openalex.org/W2084365384","https://openalex.org/W2095287544","https://openalex.org/W2103233391","https://openalex.org/W2117569814","https://openalex.org/W2126477123","https://openalex.org/W2127024723","https://openalex.org/W2128656535","https://openalex.org/W2157761630","https://openalex.org/W2171358858","https://openalex.org/W2329036234","https://openalex.org/W2367941480","https://openalex.org/W4231031590","https://openalex.org/W6631539384","https://openalex.org/W6633373722","https://openalex.org/W6634669884","https://openalex.org/W6679002403"],"related_works":["https://openalex.org/W4254354347","https://openalex.org/W7096734760","https://openalex.org/W1532893639","https://openalex.org/W1975828071","https://openalex.org/W4252615354","https://openalex.org/W2004348534","https://openalex.org/W7028776708","https://openalex.org/W1998391237","https://openalex.org/W2164028579","https://openalex.org/W2343453515"],"abstract_inverted_index":{"Excepting":[0],"surgical":[1],"resection,":[2],"there":[3],"is":[4,22],"no":[5],"efficient":[6,40],"treatment":[7,43,171],"against":[8],"pancreatic":[9,45,93,100,166,197],"cancer.":[10],"The":[11,25],"chemotherapeutic":[12],"agent":[13],"gemcitabine":[14,38,68,104,170,190],"improves":[15],"the":[16,42,146,157,161,184],"patient's":[17],"clinical":[18],"status":[19],"but":[20],"survival":[21],"not":[23],"prolonged.":[24],"aim":[26],"of":[27,44,76,92,124,135,143,183,193],"this":[28],"study":[29],"was":[30],"to":[31,36,103,133,169,172],"design":[32],"a":[33,53,151],"new":[34],"strategy":[35],"render":[37],"more":[39],"in":[41,82,85,87,96,109,114,121,127,187],"cancer":[46,94,101,167,198],"using":[47,145],"gene":[48,55,78,141,163,186],"therapy.":[49],"We":[50,118],"have":[51],"generated":[52],"fusion":[54,162],"(DCK::UMK)":[56],"combining":[57],"deoxycytidine":[58],"kinase":[59,64],"(DCK)":[60],"and":[61,84,113,178],"uridine":[62],"monophosphate":[63],"(UMK),":[65],"which":[66],"converts":[67],"into":[69],"its":[70],"toxic":[71],"phosphorylated":[72],"metabolite.":[73],"Antitumor":[74],"effects":[75],"DCK::UMK":[77,98,125,144,164,185],"expression":[79,123],"were":[80],"tested":[81],"vitro":[83,110],"vivo":[86,115,122,139],"an":[88,128],"orthotopic":[89],"transplantable":[90],"model":[91],"established":[95],"hamsters.":[97],"sensitizes":[99,165],"cells":[102,168],"by":[105,176],"reducing":[106],"dramatically":[107],"both":[108],"cell":[111,174],"viability":[112],"tumor":[116,153,179],"volume.":[117],"found":[119],"that":[120,160],"resulted":[126],"antitumor":[129],"bystander":[130],"effect":[131],"due":[132],"apoptosis":[134,177],"untransduced":[136],"cells.":[137],"In":[138],"intratumoral":[140],"transfer":[142],"synthetic":[147],"carrier":[148],"PEI":[149],"induced":[150],"potent":[152],"regression.":[154,180],"Taken":[155],"together,":[156],"results":[158],"show":[159],"induce":[173],"death":[175],"Intratumoral":[181],"delivery":[182],"combination":[188],"with":[189],"might":[191],"be":[192],"high":[194],"interest":[195],"for":[196],"management.":[199]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":1},{"year":2019,"cited_by_count":2},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":6},{"year":2014,"cited_by_count":6},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":7}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}